Characterization of T-cell repertoire of the bone marrow in immune- mediated aplastic anemia: Evidence for the involvement of antigen-driven T- cell response in cyclosporine-dependent aplastic anemia

Blood

Volumn 93, Issue 9, 1999, Pages 3008-3016

  Zeng, Weihua ^a   Nakao, Shinji ^a   Takamatsu, Hideyuki ^a   Yachie, Akihiro ^a   Takami, Akiyoshi ^a   Kondo, Yukio ^a   Sugimori, Naomi ^a   Yamazaki, Hirohito ^a   Miura, Yuji ^a   Shiobara, Shintaro ^a   Matsuda, Tamotsu ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY;

ADULT; AGED; AMINO ACID SEQUENCE; ANEMIA; APLASTIC ANEMIA; ARTICLE; BONE MARROW; CLINICAL ARTICLE; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0033135936     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.9.3008     Document Type: Article

References (40)

1. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mon PG, Saracco P, Todeschini G, Cosar P, Lacopino P, van Lint MT, Gluckman E, for the European Group for Blood and Marrow Transplantation (EBMT) Working Party on SAA: Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party. Blood 85:1348, 1995
2. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85:3058, 1995
3. Young NS: Pathophysiology II: Immune suppression of hematopoiesis, in Young NS, Alter BP (eds): Aplastic Anemia Acquired and Inherited. Philadelphia, PA, Saunders, 1994, p 68
4. Kagan WA, Ascensao JA, Pahwa RN, Hansen JA, Goldstein G, Valera EB, Incefy GM, Moore MAS, Good RA: Aplastic anemia: Presence in human bone marrow of cells that suppress myelopoiesis. Proc Natl Acad Sci USA 73:2890, 1976
5. Hoffmann R, Zanjani E, Lutton JD, Zalusky R, Wasserman LR: Suppression of erythrocyte-colony formation by lymophocytes from patients with aplastic anemia. N Engl J Med 296:10, 1977
6. Ascensao J, Pahaw R, Kagan W, Hansen J, Moore MAS, Good R: Aplastic anemia: Evidence for an immunological mechanism. Lancet 1:669, 1976
7. Zoumbos NC, Gascon P, Djeu JY, Young NS: Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82:188, 1985
8. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geissler K, Hocker P, Huber C, Kalhs P, Knapp W, Koller U, Lechner K, Volcplatzer B: Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72:266, 1988
9. Nakao S, Yamaguchi M, Shiobara S, Yokoi T, Miyawaki T, Taniguchi T, Matsuda T: Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 79:2532, 1992
10. Nistico A, Young NS: Gamma-interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 120:463, 1994
11. Viale M, Merli A, Bacigalupo A: Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78:1268, 1991
12. Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS: Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257, 1985
13. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102, 1994
14. + T cell clone recognizing autologous hematopoietic progenitor cells from a patient with immune-mediated aplastic anemia. Exp Hematol 23:433, 1995
15. Nakao S, Takami A, Takamatsu H, Zeng W, Sugimori N, Yamazaki H, Miura M, Ueda M, Shiobara S, Yoshioka T, Kaneshige T, Yasukawa M, Matsuda T: Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood 89:3691, 1997
16. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, Shimonkevitz R, Sherritt M, Rothbard J, Bernard CC, Steinman L: Selection for T-cell receptor V β-D β-J β gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68, 1993
17. Allegretta M, Albertini RJ, Howell MD, Smith LR, Martin R, McFarland HF, Sriram S, Brostoff S, Steinman L: Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest 94:105, 1994
18. + T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc Natl Acad Sci USA 93:12461, 1996
19. + T cells in rheumatoid arthritis. J Clin Invest 94:2068, 1994
20. Li Y, Sun GR, Tumang JR, Crow MK, Friedman SM: CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. J Clin Invest 94:2525, 1994
21. Pannetier C, Even J, Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 16:176, 1995
22. Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, Mora M, Cornelio F, Steinman L: Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V α/β rearrangements may indicate antigen-driven selection. J Clin Invest 91:2880, 1993
23. Nakao S, Takamatsu H, Chuhjo T, Ueda M, Shiobara S, Matsuda T, Kaneshige T, Mizoguchi H: Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood 84:4257, 1994
24. Osman I, Meral B, Onder A, Muhit O, Haluk K, Hamdi A, Gunhan G, Nahide K, Akin U: HLA DR2: A predictive marker in response to cyclosporine therapy in aplastic anemia. Int J Hematol 66:291, 1997
25. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162:156, 1987
26. Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C, Flomenberg N: Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 152:5109, 1994
27. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P: The size of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germline segments. Proc Natl Acad Sci USA 90:4319, 1993
28. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J: Interaction of Staphyhcoccus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 86:8941, 1989
29. Labrecque N, McGrath H, Subramanyam M, Huber BT, Sekaly RP: Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features. J Exp Med 177:1735, 1993
30. Jeffrey RC, Harold D, Karyl SB, Patricia JK, Mary AR: Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol 48:39, 1996
31. Regnault A, Cumano A, Vassalli P, Guy-Grand D, Kourilsky P: Oligoclonal repertoire of the CD8αα and the CD8αβ TCR-α/β murine intestinal intraepithelial T lymphocytes: Evidence for the random emergence of T cells. J Exp Med 180:1345, 1994
32. Yamamoto K, Sakoda H, Nakajima T, Kato T, Okubo M, Dohi M, Mizushima Y, Ito M, Nishioka K: Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 4:1219, 1992
33. Melenhorst JJ, Fibbe WE, Struyk L, van der Elsen, Willemze R, Landegent JE: Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia. Br J Haematol 96:85, 1997
34. Manz CY, Dietrich PY, Schnuriger V, Nissen C, Wodnar-Filipowicz A: T-cell receptor β chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia. Blood Cells Mol Dis 23:110, 1997
35. + T cells in persistent infection with lymphocytic choriomeningitis virus. J Exp Med 187:1903, 1998
36. Kawano Y, Nissen C, Gratwohl A, Speck B: Immunostimulatory effects of different antilymphocyte globulin preparations: A possible clue to their clinical effect. Br J Haematol 68:115, 1988
37. Morel PA, Livingstone AM, Fathman CG: Correlation of T-cell receptor Vβ gene family with MHC restriction. J Exp Med 166:583, 1987
38. + T cell clones in elderly humans. J Immunol 158:4493, 1997
39. Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR: Selective activation and accumulation of oligoclonal V β-specific T cells in active pulmonary sarcoidosis. J Clin Invest 94:1533, 1994
40. Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows SR, Burrows JM, Moss DJ, Argaet VP, Misko IS: Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in infectious mononucleosis. J Exp Med 184:1815, 1996